AstraZeneca spins out new firm Viela Bio

by | Feb 28, 2018 | | 0

AstraZeneca’s biologics research and development arm MedImmune has spun out six molecules from its early-stage inflammation and autoimmunity programmes into new independent biotech Viela Bio.

Read More